EX-23.2 4 tm2039346d1_ex23-2.htm EXHIBIT 23.2

Exhibit 23.2


Independent Registered Public Accounting Firm’s Consent


We consent to the inclusion in this Registration Statement of Reviva Pharmaceuticals Holdings Inc.  (formerly Tenzing Acquisition Corp.) on Form S-1 of our report dated May 1, 2020 which includes an explanatory paragraph as to the Company’s ability to continue as a going concern  with respect to our audits of the financial statements of Tenzing Acquisition Corp. as of February 29, 2020 and February 28, 2019  and for the year ended February 29, 2020 and for the period from March 20, 2018 (inception) through February 28, 2019, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.


/s/ Marcum llp


Marcum llp

New York, New York 

December 29, 2020